Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Severe cutaneous adverse reactions and burn-centre care
Essential points for quick revision.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Painful skin or mucosal loss
Skin pain, dusky atypical targets, blisters, detachment or erosions at mouth, eyes or genital mucosa after a medicine can herald SJS/TEN; shock, hypoxia, oliguria, confusion or rapidly rising organ tests signals acute skin and multiorgan failure.
Action: Stop suspected culprit medicine immediately, assess ABCDE and airway, obtain urgent dermatology and critical-care review, discuss rapid transfer to an age-appropriate Burns Centre or specialised dermatology centre co-located with intensive care, and begin warm, gentle, non-adhesive supportive care without waiting for biopsy.
Synopsis
Recognise SJS/TEN, DRESS and AGEP early, stop the most likely culprit safely, distinguish epidermal loss from mimics, and deliver multidisciplinary skin-failure, mucosal, ocular and organ care through the appropriate specialist centre.
SJS/TEN typically causes prodrome, disproportionate skin pain, dusky macules or atypical targets, flaccid blisters, epidermal detachment and prominent ocular, oral or genital erosions.
Classify by detached or detachable surface: SJS below 10%, overlap 10% to 30%, and TEN above 30%; extent can evolve after presentation and must be remapped.
DRESS usually emerges two to eight weeks after starting a culprit with fever, widespread eruption, facial oedema, nodes, eosinophilia or atypical lymphocytes and liver, kidney, lung or cardiac injury.
Key red flags
Skin pain, epidermal tenderness, dusky or blistering targets, positive shearing, any mucosal erosion, facial oedema with fever, eosinophilia or organ injury, pustules with systemic illness, hypotension, hypoxia, oliguria, confusion, rising transaminases, myocarditis symptoms or a rapidly spreading eruption requires same-day hospital and dermatology assessment.
Acute skin failure
Hypothermia, tachycardia, hypotension, oliguria, confusion, severe pain, expanding detachment or hypoxia indicates barrier and organ failure regardless of the named SCAR.
Investigation priorities
01
Medicine chronology and causality assessmentFirst step
Identify the likely culprit quickly enough to reduce ongoing injury.
Management branches
First-line emergency sequenceStop culprit and transfer early
Painful blistering, epidermal loss or severe mucositis raises SJS/TEN or another SCAR.
Stop the likely culprit immediately, preserve essential treatment with safe alternatives, assess ABCDE and airway, weigh the patient and map skin and every mucosal site.
Contact dermatology, critical care and the regional specialised service early; arrange care in an age-specific Burns Centre or dermatology centre co-located with intensive care.
Key medicines
White soft paraffin and liquid paraffin 50:50 ointmentApply gently over intact and denuded epidermis after warmed cleansing and whenever the surface dries, generally at least every 4 hours during acute specialist care.
Weight-adjusted LMWH thromboprophylaxisGive the hospital protocol's prophylactic subcutaneous dose once daily, adjusted for body weight and renal function, while mobility is substantially reduced unless contraindicated.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
PubMed record for UK adult SJS TEN guidelineCulprit withdrawal, SCORTEN, specialist setting, fluids, wounds, infection, eye and mucosal care, active-therapy uncertainty and follow-up.
BAD SJS TEN patient leafletCurrent patient-facing recognition, causes, hospital treatment and long-term medicine avoidance.